Letters
Advice on homoeopathic products
Authors’ reply to Fisher and 47 colleagues
BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6693 (Published 18 October 2011) Cite this as: BMJ 2011;343:d6693
- Susan Bewley, obstetric consultant1
- On behalf of Edzard Ernst, John Garrow, Nick Ross, Les Rose, Michael Baum, James May, Alain Braillon, David Bender
- 1King’s Health Partners, London SE1 7EH, UK
- susan.bewley{at}kcl.ac.uk
We rise to the challenge to critically evaluate the five articles mustered in defence of homoeopathy by Fisher and 47 colleagues.1
The meta-analysis by Wiesenauer and Luedtke included eight randomised controlled trials (RCTs).2 A re-analysis of the four published placebo controlled RCTs revealed serious flaws, including non-validated outcome measures, all the studies originating from Wiesenauer’s own group, and a lack of independent replication.3 Furthermore, relatively low dilutions were used, which contain active molecules …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.